Clinical Trials Logo

Hemianopsia clinical trials

View clinical trials related to Hemianopsia.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06362434 Not yet recruiting - Hemianopsia Clinical Trials

Visual Telerehabilitation in Children, Adolescents and Young Adults With Hemianopsia Consecutive to a Brain Tumour

HHREHAB
Start date: June 1, 2024
Phase: N/A
Study type: Interventional

Brain malignancies are the most common cause of death from cancer in the pediatric population and a major source of morbidity amongst survivors. Many children with a brain tumour often suffer from visual field defects (hemianopia) dramatically impacting their daily life with poorer social interaction, difficulties learning, playing sports and engaging with peers. Practically, they bump into people and objects and have problems in finding their way in unfamiliar places and in detecting incoming objects in their blind field. There is growing recognition of the diverse and deep impact of hemianopia on physical and mental health, quality of life, and social outcomes of the affected individuals and their family. However, despite the frequent impact of brain tumours on the visual function and functional vision, ophthalmologic evaluations are not standard of care for all brain tumour patients and there are no standardized protocols of vision loss management in the pediatric population with hemianopia. There is an unmet need of restoring perception in the blind field in individuals with hemianopia consecutive to pediatric brain tumor. Our laboratory has developed a visual rehabilitation procedure based on the combination of adaptative audio and visual target tracking in a 3D environment in virtual reality. Participants perform audiovisual stimulation at home in a headset, with remote control from the laboratory. Preliminary on data on paediatric patients with hemianopia consecutive to a brain tumour indicate feasibility and potential effectiveness of a 6-week Re:Vision program on visual fields, visual perception and quality of life. Our objective is to evaluate the effectiveness of Re:Vision, an 8-week visual telerehabilitation program, on visual perception in 50 individuals aged 10-40 years old with hemianopia consecutive to a pediatric brain tumor in a phase IIa/b multi-centric clinical study across Canada. This intervention provides more equitable access to individuals, with the ability to receive rehabilitation therapy at home without supervision by a healthcare professional, meaning that Canadians living outside urban centres could take advantage of specialized therapies with remote supervision. This is the first study that could lead to a major change in the management of these patients. It could open the door for visual rehabilitation strategies to other population of visually impaired children, significantly impacting public health strategies.

NCT ID: NCT06352086 Not yet recruiting - Stroke, Ischemic Clinical Trials

Understanding Visual Processing After Occipital Stroke

Start date: September 2024
Phase:
Study type: Observational

The purpose of this study is to investigate how visual orientation discrimination and metacognition (i.e., perceptual confidence) are affected by occipital stroke that causes hemianopia and quadrantanopia in adults. This research will provide insight as to how the residual visual system, which not directly damaged by the occipital stroke, processes orientation (assayed in terms of orientation discrimination) and metacognition (by measuring perceptual confidence for orientation discrimination). These measures will be used to refine computational models that attempt to explain how the brain copes with loss of primary visual cortex (V1) as a result of stroke. This knowledge is essential to devise more effective visual rehabilitation therapies for patients suffering from occipital strokes.

NCT ID: NCT06266949 Not yet recruiting - Pituitary Tumor Clinical Trials

Perimetry Based on Eye-movements in Patients With (Supra)Sellar Tumors

Start date: August 1, 2024
Phase:
Study type: Observational

The purpose of this study is to assess wether the SONDA visual field test is suitable for patients with a supra sellar tumour.

NCT ID: NCT06136169 Not yet recruiting - Clinical trials for Homonymous Hemianopia

Reminder-cue Scanning Training for Homonymous Visual Field Loss

Start date: May 2024
Phase: N/A
Study type: Interventional

This study will evaluate a new approach to training people with visual field loss to scan when driving

NCT ID: NCT05894434 Not yet recruiting - Clinical trials for Hemianopia, Homonymous

Ameliorating Stroke-induced Hemianopia Via Multisensory Training

Start date: August 2024
Phase: N/A
Study type: Interventional

This study seeks to determine the extent of the visual capabilities that can be restored in hemianopic stroke patients by a multisensory training technique and evaluate changes in the brain that the training induces. The effectiveness of the technique will be evaluated in two interventional contexts: patients whose blindness is long-standing and stable, and another in which intervention is as soon as possible after the stroke.

NCT ID: NCT02405143 Not yet recruiting - Stroke Clinical Trials

Restoration of Vision After Stroke

REVIS
Start date: April 2015
Phase: N/A
Study type: Interventional

Occipital stroke is associated with homonymous visual field defects (occurring on one side of the visual field). Despite spontaneous recovery, some degree of defect is often permanent. Currently, no treatment exists for such visual field defects.The purpose of this study is to test the efficacy of a type of electrical brain stimulation method, transcranial alternating current stimulation, in reducing these type of visual field defects in their chronic stage.